These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38007439)

  • 1. ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer.
    Chen C; Zhai E; Liu Y; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Chen J; Cai S
    Cancer Cell Int; 2023 Nov; 23(1):293. PubMed ID: 38007439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer.
    Sun M; Yue Y; Wang X; Feng H; Qin Y; Chen M; Wang Y; Yan S
    Exp Cell Res; 2024 Apr; 437(1):113994. PubMed ID: 38479704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.
    Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
    Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
    Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.
    Wang S; Nie J; Xu K; Liu Y; Tong W; Li A; Zuo W; Liu Z; Yang F
    Aging (Albany NY); 2023 Sep; 15(18):9590-9613. PubMed ID: 37724907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
    Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
    Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
    Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
    Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced m6A demethylase ALKBH5 promotes ovarian cancer tumorigenicity by decreasing methylation of the lncRNA RMRP.
    Lyu Y; Wang Y; Ding H; Li P
    Am J Cancer Res; 2023; 13(9):4179-4191. PubMed ID: 37818080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 15. RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.
    Li R; Wu X; Xue K; Feng D; Li J; Li J
    Biomark Res; 2023 Mar; 11(1):30. PubMed ID: 36899424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
    Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
    Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.
    Shen W; Pu J; Zuo Z; Gu S; Sun J; Tan B; Wang L; Cheng J; Zuo Y
    Cancer Cell Int; 2022 Nov; 22(1):353. PubMed ID: 36376862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of signature for prognosis and immune microenvironment in gastric cancer based on m6A demethylase ALKBH5.
    Ji T; Gao X; Li D; Huai S; Chi Y; An X; Ji W; Yang S; Li J
    Front Oncol; 2022; 12():1079402. PubMed ID: 36686788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.